203 related articles for article (PubMed ID: 23681790)
1. [Antipsychotic polypharmacy in high-utilising patients with schizophrenia].
Schmidt-Kraepelin C; Puschner B; Loos S; Janssen B
Psychiatr Prax; 2013 Oct; 40(7):380-4. PubMed ID: 23681790
[TBL] [Abstract][Full Text] [Related]
2. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
Kilian R; Angermeyer MC
Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
[TBL] [Abstract][Full Text] [Related]
3. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
Cook B; Hoogenboom G
Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
[TBL] [Abstract][Full Text] [Related]
4. A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.
Honer WG; Procyshyn RM; Chen EY; MacEwan GW; Barr AM
J Psychiatry Neurosci; 2009 Nov; 34(6):433-42. PubMed ID: 19949719
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
6. Emerging guidelines for the use of antipsychotic polypharmacy.
Stahl SM
Rev Psiquiatr Salud Ment; 2013; 6(3):97-100. PubMed ID: 23485567
[No Abstract] [Full Text] [Related]
7. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
Velligan DI; Carroll C; Lage MJ; Fairman K
Psychiatr Serv; 2015 Feb; 66(2):127-33. PubMed ID: 25321616
[TBL] [Abstract][Full Text] [Related]
8. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
[TBL] [Abstract][Full Text] [Related]
9. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics].
Geronimi-Ferret D; Lesay M; Barges-Bertocchio MH; Cornet-Bonnefont M; Robert H
Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402
[TBL] [Abstract][Full Text] [Related]
10. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center].
Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P
Encephale; 1998; 24(4):365-77. PubMed ID: 9809242
[TBL] [Abstract][Full Text] [Related]
11. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
Zink M; Knopf U; Henn FA; Thome J
Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
[TBL] [Abstract][Full Text] [Related]
12. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.
Ganguly R; Kotzan JA; Miller LS; Kennedy K; Martin BC
J Clin Psychiatry; 2004 Oct; 65(10):1377-88. PubMed ID: 15491242
[TBL] [Abstract][Full Text] [Related]
15. Management of treatment resistant schizophrenia unresponsive to clozapine.
Barnes TR; McEvedy CJ; Nelson HE
Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653
[No Abstract] [Full Text] [Related]
16. Clozapine-associated asterixis: case report.
Kwak YT; Yang Y; Koo MS
J Clin Psychopharmacol; 2014 Feb; 34(1):165-7. PubMed ID: 24158019
[No Abstract] [Full Text] [Related]
17. [Antipsychotic drug combinations in the treatment of schizophrenia. A review of the literature].
Gazdag G; Tolna J; Bitter I
Neuropsychopharmacol Hung; 2012 Sep; 14(3):189-95. PubMed ID: 22987732
[TBL] [Abstract][Full Text] [Related]
18. Switching antipsychotic medications: a 2-year chart-review study exploring patient characteristics and psychiatric service use of schizophrenia patients.
Schneider AL; Mosier KE; Tempier RP
J Clin Psychiatry; 2009 Jun; 70(6):937-9. PubMed ID: 19573492
[No Abstract] [Full Text] [Related]
19. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).
Lieberman JA
Arch Gen Psychiatry; 2006 Oct; 63(10):1069-72. PubMed ID: 17015808
[No Abstract] [Full Text] [Related]
20. Polypharmacy in schizophrenia.
Zink M; Englisch S; Meyer-Lindenberg A
Curr Opin Psychiatry; 2010 Mar; 23(2):103-11. PubMed ID: 20051861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]